Biovac Nepal Private Limited is a vaccine research, development and manufacturing company based in Nepal. It uses the latest technologies to understand disease burden, dynamics, evaluate novel vaccine targets, and manufacture vaccines that have high efficacy and are cost effective. It
specializes in field based disease surveillance, molecular diagnostic and genomics based disease detection and vaccine target evaluation, stabilization and manufacturing. It partners with world’s leading institutions on vaccine research and development, including Newcastle I-2 vaccine developer- the University of Queensland.